Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s), announced that it has acquired MenoLabs business, a leading women’s health and dietary supplement branded portfolio from Amyris, Inc. (Amyris) in Amyris’ Chapter 11 sales process. Dr. Reddy’s acquired the entire MenoLabs supplements portfolio which includes seven branded products designed to provide health support and address symptoms of perimenopause…
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited. The portfolio includes approximately 45 commercial products, four pipeline…
Dr. Reddy’s Laboratories Ltd. announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois, based Eton Pharmaceuticals, Inc. The portfolio includes the Biorphen (phenylephrine hydrocholoride) Injection and Rezipres (ephedrine hydrochloride) Injection NDAs with nine separate combinations of strengths and presentations and one firstto-file approved ANDA for Cysteine Hydrochloride…